FDA Approval has been waited for by the companies and the people. There had been a lot of debate which is still ongoing about the booster shots and the need for them. Everyone is divided into two factions, some believe that it is needed while the others believe that it is not needed at all.

However, in the middle of all this Pfizer had got its FDA approval from the FDA. The FDA had allowed the booster shot to be administered to people who are above the age of 65 and to people who are prone to sickness and very vulnerable.

FDA authorizes Pfizer’s Covid booster shots for people 65 and older and other vulnerable Americans

This decision was not taken overnight but it was coming to a conclusion fairly soon. The agency meeting that had taken place had put the place into perspective. People have voted to not give this vaccine to young people yet but a very great deal had been debated and they have announced to give the vaccine to older people. The vote was unanimous in this case. However, you must be wondering that how much even is the old population of the country.

They are Actually comprising of 17% of the entire population and even though they are at a lower number than the other population, they are still at more risk of being affected by the coronavirus and there is a 77% chance of them dying because of it. So we can say that they are the most vulnerable age group in the country.

The agency had also made the note of including a broad definition for the people from 18 to 64 years old who might be eligible for the vaccine. They include the people who are having serious medical conditions.

They are the ones at a chance of being really sick. The ones who might be the people who are working in the nursing homes, prisons, and front-line health care are also going to be eligible for the vaccine booster shots.

“The FDA had tried to and considered the committee’s input and then they have gone ahead and conducted its own thorough review of the submitted data in order for them to reach today’s decision,” Dr. Peter Marks, said in a statement to the press.

“We will obviously not stop and continue to analyze data submitted to the FDA pertaining to the use of booster doses of COVID-19 vaccines and we will be making more decisions as need to be based on the data that we are given.”

This is obviously a controversial matter and topic and the decision is praised by some while the others are scoffing at it. We do not know what the future holds but we will keep you updated.